TREATMENT OF ACUTE PROMYELOCYTIC LEUKEMIA WITH AIDA BASED REGIMEN
<p class="MsoNormal" style="text-align: justify; line-height: 200%; margin: 0cm 0cm 0pt;"><span style="font-size: small;"><span style="font-family: Times New Roman;"><span lang="EN-GB" style="mso-...
Saved in:
| Main Authors: | , , , , , , , , , , , , , , , , , |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
PAGEPress Publications
2011-01-01
|
| Series: | Mediterranean Journal of Hematology and Infectious Diseases |
| Subjects: | |
| Online Access: | http://www.mjhid.org/article/view/8662 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
| _version_ | 1850215583587500032 |
|---|---|
| author | Hela Ben Abid Zaher Belhadjali Samia Menif Naouel Ben Salah Raihane Ben Lakhal Lamia Aissaoui Hend Ben Neji Zarrouk Mohamed Kacem Karima Yosr Ben Abdennebi Ramzi Ben Amor Hèla Ghédira Ramzi Jeddi Emna Gouider Raouf Hafsia Ali Saad Pierre Fenaux Balkis Meddeb |
| author_facet | Hela Ben Abid Zaher Belhadjali Samia Menif Naouel Ben Salah Raihane Ben Lakhal Lamia Aissaoui Hend Ben Neji Zarrouk Mohamed Kacem Karima Yosr Ben Abdennebi Ramzi Ben Amor Hèla Ghédira Ramzi Jeddi Emna Gouider Raouf Hafsia Ali Saad Pierre Fenaux Balkis Meddeb |
| author_sort | Hela Ben Abid |
| collection | DOAJ |
| description | <p class="MsoNormal" style="text-align: justify; line-height: 200%; margin: 0cm 0cm 0pt;"><span style="font-size: small;"><span style="font-family: Times New Roman;"><span lang="EN-GB" style="mso-ansi-language: EN-GB;">In Tunisia, the ATRA era began in 1998 with the use, consecutively, of two regimens combining ATRA and an anthracycline with cytarabine (APL93), and without cytarabine (LPA99). From 2004, 51 patients with confirmed APL either by t(15;17) or PML/RARA were treated according to the PETHEMA LPA 99 trial. Forty three patients achieved CR (86%). The remaining seven patients had early death (one died before treatment onset): four caused by differentiation syndrome (DS) and three died from central nervous system hemorrhage.</span><span lang="EN-GB" style="font-family: AdvP497E2; mso-bidi-font-family: AdvP497E2; mso-ansi-language: EN-GB;"> Multivariate analysis revealed that female gender (P=0.045), baseline WBC&gt; 10 G/L ( </span><span lang="EN-GB" style="font-family: AdvP497E3; mso-bidi-font-family: AdvP497E3; mso-ansi-language: EN-GB;">P=0.041</span><span lang="EN-GB" style="font-family: AdvP497E2; mso-bidi-font-family: AdvP497E2; mso-ansi-language: EN-GB;">) and serum creatinine &gt; 1.4mg/dl ( P=0.021) were predictive of mortality during induction. </span><span lang="EN-GB" style="mso-ansi-language: EN-GB;"><span style="mso-spacerun: yes;"> </span>DS was observed in 16 patients (32%) after a median onset time of 15 days from treatment onset (range, 2–29). Body mass index ≥ 30 (P=0.01) was the only independent predictor of DS. Occurrence of hypertensive peaks significantly predicted occurrence of DS (P=0.011) and was significantly associated with high BMI (p=0.003). With a median follow-up of<span style="mso-spacerun: yes;"> </span>50 months, 5 year cumulative incidence of relapse, event free and overall survival were 4.7%, 74% and 78%, respectively.</span></span></span></p> |
| format | Article |
| id | doaj-art-710d67a3c5c64dc985e0c4da4e3347e3 |
| institution | OA Journals |
| issn | 2035-3006 |
| language | English |
| publishDate | 2011-01-01 |
| publisher | PAGEPress Publications |
| record_format | Article |
| series | Mediterranean Journal of Hematology and Infectious Diseases |
| spelling | doaj-art-710d67a3c5c64dc985e0c4da4e3347e32025-08-20T02:08:35ZengPAGEPress PublicationsMediterranean Journal of Hematology and Infectious Diseases2035-30062011-01-0131e2011033e2011033TREATMENT OF ACUTE PROMYELOCYTIC LEUKEMIA WITH AIDA BASED REGIMENHela Ben AbidZaher BelhadjaliSamia MenifNaouel Ben SalahRaihane Ben LakhalLamia AissaouiHend Ben NejiZarrouk MohamedKacem KarimaYosr Ben AbdennebiRamzi Ben AmorHèla GhédiraRamzi JeddiEmna GouiderRaouf HafsiaAli SaadPierre FenauxBalkis Meddeb<p class="MsoNormal" style="text-align: justify; line-height: 200%; margin: 0cm 0cm 0pt;"><span style="font-size: small;"><span style="font-family: Times New Roman;"><span lang="EN-GB" style="mso-ansi-language: EN-GB;">In Tunisia, the ATRA era began in 1998 with the use, consecutively, of two regimens combining ATRA and an anthracycline with cytarabine (APL93), and without cytarabine (LPA99). From 2004, 51 patients with confirmed APL either by t(15;17) or PML/RARA were treated according to the PETHEMA LPA 99 trial. Forty three patients achieved CR (86%). The remaining seven patients had early death (one died before treatment onset): four caused by differentiation syndrome (DS) and three died from central nervous system hemorrhage.</span><span lang="EN-GB" style="font-family: AdvP497E2; mso-bidi-font-family: AdvP497E2; mso-ansi-language: EN-GB;"> Multivariate analysis revealed that female gender (P=0.045), baseline WBC&gt; 10 G/L ( </span><span lang="EN-GB" style="font-family: AdvP497E3; mso-bidi-font-family: AdvP497E3; mso-ansi-language: EN-GB;">P=0.041</span><span lang="EN-GB" style="font-family: AdvP497E2; mso-bidi-font-family: AdvP497E2; mso-ansi-language: EN-GB;">) and serum creatinine &gt; 1.4mg/dl ( P=0.021) were predictive of mortality during induction. </span><span lang="EN-GB" style="mso-ansi-language: EN-GB;"><span style="mso-spacerun: yes;"> </span>DS was observed in 16 patients (32%) after a median onset time of 15 days from treatment onset (range, 2–29). Body mass index ≥ 30 (P=0.01) was the only independent predictor of DS. Occurrence of hypertensive peaks significantly predicted occurrence of DS (P=0.011) and was significantly associated with high BMI (p=0.003). With a median follow-up of<span style="mso-spacerun: yes;"> </span>50 months, 5 year cumulative incidence of relapse, event free and overall survival were 4.7%, 74% and 78%, respectively.</span></span></span></p>http://www.mjhid.org/article/view/8662Leukemia |
| spellingShingle | Hela Ben Abid Zaher Belhadjali Samia Menif Naouel Ben Salah Raihane Ben Lakhal Lamia Aissaoui Hend Ben Neji Zarrouk Mohamed Kacem Karima Yosr Ben Abdennebi Ramzi Ben Amor Hèla Ghédira Ramzi Jeddi Emna Gouider Raouf Hafsia Ali Saad Pierre Fenaux Balkis Meddeb TREATMENT OF ACUTE PROMYELOCYTIC LEUKEMIA WITH AIDA BASED REGIMEN Mediterranean Journal of Hematology and Infectious Diseases Leukemia |
| title | TREATMENT OF ACUTE PROMYELOCYTIC LEUKEMIA WITH AIDA BASED REGIMEN |
| title_full | TREATMENT OF ACUTE PROMYELOCYTIC LEUKEMIA WITH AIDA BASED REGIMEN |
| title_fullStr | TREATMENT OF ACUTE PROMYELOCYTIC LEUKEMIA WITH AIDA BASED REGIMEN |
| title_full_unstemmed | TREATMENT OF ACUTE PROMYELOCYTIC LEUKEMIA WITH AIDA BASED REGIMEN |
| title_short | TREATMENT OF ACUTE PROMYELOCYTIC LEUKEMIA WITH AIDA BASED REGIMEN |
| title_sort | treatment of acute promyelocytic leukemia with aida based regimen |
| topic | Leukemia |
| url | http://www.mjhid.org/article/view/8662 |
| work_keys_str_mv | AT helabenabid treatmentofacutepromyelocyticleukemiawithaidabasedregimen AT zaherbelhadjali treatmentofacutepromyelocyticleukemiawithaidabasedregimen AT samiamenif treatmentofacutepromyelocyticleukemiawithaidabasedregimen AT naouelbensalah treatmentofacutepromyelocyticleukemiawithaidabasedregimen AT raihanebenlakhal treatmentofacutepromyelocyticleukemiawithaidabasedregimen AT lamiaaissaoui treatmentofacutepromyelocyticleukemiawithaidabasedregimen AT hendbenneji treatmentofacutepromyelocyticleukemiawithaidabasedregimen AT zarroukmohamed treatmentofacutepromyelocyticleukemiawithaidabasedregimen AT kacemkarima treatmentofacutepromyelocyticleukemiawithaidabasedregimen AT yosrbenabdennebi treatmentofacutepromyelocyticleukemiawithaidabasedregimen AT ramzibenamor treatmentofacutepromyelocyticleukemiawithaidabasedregimen AT helaghedira treatmentofacutepromyelocyticleukemiawithaidabasedregimen AT ramzijeddi treatmentofacutepromyelocyticleukemiawithaidabasedregimen AT emnagouider treatmentofacutepromyelocyticleukemiawithaidabasedregimen AT raoufhafsia treatmentofacutepromyelocyticleukemiawithaidabasedregimen AT alisaad treatmentofacutepromyelocyticleukemiawithaidabasedregimen AT pierrefenaux treatmentofacutepromyelocyticleukemiawithaidabasedregimen AT balkismeddeb treatmentofacutepromyelocyticleukemiawithaidabasedregimen |